VERTEX PHARMACEUTICALS INCORPORATED

General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Implementation of P.L. 117-169 provisions related to Medicare prescription drugs; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; H.R. 7142/S. 3832 - The Alternatives to PAIN Act.

General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Patient access to non-opioid pain medicines; Issues related to FDA drug approval process; Copay accumulators and maximizers, HELP Copays Act (H.R. 830/S. 1375); General education about Alternative Funding Programs; General education about kidney disease, including APOL-1; H.R. 7085 - the BIOSECURE Act.

Issues related to corporate and international tax policy and research and development tax credits, American Innovation and R&D Competitiveness Act (H.R. 2673) and American Innovation and Jobs Act (S. 866)